Salicylamide

CAS No. 65-45-2

Salicylamide( Salicylamide | Acket | Allevin | Benesal | Cymidon | Dropsprin | Eggosalil | Panithal | Salizell | Urtosal )

Catalog No. M15487 CAS No. 65-45-2

Salicylamide is the common name for the substance o-hydroxybenzamide, or amide of salicyl.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1G 43 In Stock

Biological Information

  • Product Name
    Salicylamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Salicylamide is the common name for the substance o-hydroxybenzamide, or amide of salicyl.
  • Description
    Salicylamide is the common name for the substance o-hydroxybenzamide, or amide of salicyl. Salicylamide is a non-prescription drug with analgesic and antipyretic properties. Its medicinal uses are similar to those of aspirin. Salicylamide is used in combination with both aspirin and caffeine in the over-the-counter pain remedies.(In Vitro):Treatment with salicylamides leads to the bacterial growth inhibition which correlates with the level of inhibition of sulfate reduction.(In Vivo):Salicylamide administration decreases the levels of radiosulfate in maternal serum and placenta, and impaires the incorporation of radiosulfate into fetal skeletal GAGs. Salicylamide administration results in a decrease in the calcium content of fetal limb bones, but has no significant effect on maternal serum calcium. Salicylamide administration decreases radiosulfate uptake by maternal serum and liver, fetus and placenta--effects being dose-dependent. Differences in radiosulfate uptake by the fetus and placenta over time, induced by salicylamide, are also significant independently of maternal serum levels of radiosulfate.
  • In Vitro
    Treatment with salicylamides leads to the bacterial growth inhibition which correlates with the level of inhibition of sulfate reduction.
  • In Vivo
    Salicylamide administration decreases the levels of radiosulfate in maternal serum and placenta, and impaires the incorporation of radiosulfate into fetal skeletal GAGs. Salicylamide administration results in a decrease in the calcium content of fetal limb bones, but has no significant effect on maternal serum calcium. Salicylamide administration decreases radiosulfate uptake by maternal serum and liver, fetus and placenta--effects being dose-dependent. Differences in radiosulfate uptake by the fetus and placenta over time, induced by salicylamide, are also significant independently of maternal serum levels of radiosulfate.
  • Synonyms
    Salicylamide | Acket | Allevin | Benesal | Cymidon | Dropsprin | Eggosalil | Panithal | Salizell | Urtosal
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-1| COX-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    65-45-2
  • Formula Weight
    137.14
  • Molecular Formula
    C7H7NO2
  • Purity
    >98% (HPLC)
  • Solubility
    soluble in Water
  • SMILES
    O=C(N)C1=CC=CC=C1O
  • Chemical Name
    2-Hydroxybenzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Manin AN, et al. J Phys Chem B. 2014 Jun 19;118(24):6803-14.
molnova catalog
related products
  • SC-75416

    SC-75416 is a selective COX-2 inhibitor for the study of pain.

  • Suprofen

    Suprofen is a non-steroidal anti-inflammatory drug (NSAID).

  • Aminopar

    4-aminosalicylic acid, commonly known as PAS, is an antibiotic used to treat tuberculosis.